| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $4.2M | -51.6% |
| Cost of Revenue | $1.5M | -44.6% |
| Gross Profit | $2.7M | -54.8% |
| R&D Expense | $2.0M | +2.1% |
| SG&A Expense | $6.5M | +84.0% |
| Operating Income | -$7.1M | -2547.4% |
| Pre-tax Income | -$7.8M | -1657.8% |
| Income Tax | $318K | +400.0% |
| Net Income | -$8.1M |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.6M | +3264.0% |
| Short-term Investments | $15.9M | — |
| Accounts Receivable | $1.4M | -75.6% |
| Inventory | $1.1M | +39.7% |
| Current Assets | $33.0M | +373.3% |
| Total Assets | $42.7M | +443.1% |
| Current Liabilities | $455K | -84.3% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.1M | -73.9% |
| Capital Expenditures | $725K | — |
| Investing Cash Flow | -$22.7M | — |
| Financing Cash Flow | $41.9M | +1284.5% |
| Free Cash Flow | -$5.8M | — |
| -2301.2% |
| EPS (Basic) | -$0.12 | -1100.0% |
| EPS (Diluted) | -$0.12 | -1100.0% |
| Total Liabilities |
| $913K |
| -70.0% |
| Stockholders' Equity | $41.7M | +767.9% |